Artia Global Partners »

Newamsterdam Pharma Co Nv shares owned by Artia Global Partners

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 54k 23.65

More positions owned by Artia Global Partners

Eli Lilly & Co Put Put Option
Novo-nordisk A S Adr (NVO)
Eli Lilly & Co. (LLY)
Merck & Co (MRK)
Viking Therapeutics (VKTX)
Abbvie (ABBV)
Intra Cellular Therapies (ITCI)
Argenx Se Sponsored Adr (ARGX)
Astrazeneca Sponsored Adr (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Axsome Therapeutics (AXSM)
Ocular Therapeutix (OCUL)
Cytokinetics Com New (CYTK)
Neurocrine Biosciences (NBIX)
Disc Medicine (IRON)

View all positions for Artia Global Partners

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
Viking Global Investors
RA Capital Management
Medicxi Ventures Management
Adage Capital Partners GP
BVF
Cormorant Asset Management
Goldman Sachs Group
Millennium Management
GMT Capital Corp
Jennison Associates
Artal Group
Deerfield Management Company

View all funds holding Newamsterdam Pharma Co Nv